Allergan Acquires Bonti Inc, Maker of Fast-Acting Injectable

October 2, 2018 Tags: , , , , , , ,

allergan needle pink tinted

Allergan, the global pharmaceutical company behind Botox Cosmetic, Juvederm fillers and Kybella,  announced that it is acquiring Bonti Inc. Bonti Inc has been developing a new neuromodulator called EB-001 to be used for both cosmetic and therapeutic use. Current neuromodulators on the market are Botox, Dysport, and Xeomin. These products take about a week for patients to see results while EB-001 is expected to take effect within 24 hours.

Learn more with this article: http://www.plasticsurgerypractice.com/2018/09/botox-maker-allergan-just-acquired-revolutionary-new-neuromodulator/?ref=fr-title